The Lancet Rheumatology in conversation with
by The Lancet Group
Mrinalini Dey on the association between health literacy and…
About this podcast
Editors at The Lancet Rheumatology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from disorders of the immune system to sex and gender in research design, the transitional care for adolescent patients with rheumatic diseases to care for undocumented immigrants, and more.
Episodes
The newest 20 of 38 episodes
- Mrinalini Dey on the association between health literacy and outcomes in people with inflammatory arthritis · 20 min · Episode 5In August’s episode, Dr Mrinalini Dey from the Centre for Rheumatic Diseases at King’s College London discusses her recent publication on the association between health literacy…
- Enpatoran for Cutaneous or Systemic Lupus with Eric Morand · 18 min · Episode 4In today’s episode Professor Eric Morand discusses the results of Cohort A and Cohort B of the WILLOW trial which investigated the efficacy and safety of enpatoran, a novel, oral…
- Tue Wenzel Kragstrup on GLP-1 and DPP-4 in the synovial fluid of patients with rheumatic disease · 15 min · Episode 3In this month’s podcast, we explore Associate Professor Kragstrup’s recent proof-of-concept study which reports glucagon-like peptide-1 (GLP-1) concentrations and dipeptidyl…
- Dirk Foell on trends in paediatric rheumatology care across Europe · 16 min · Episode 2In this episode, Professor Dirk Foell from University Hospital Münster unpacks the findings from a recent Europe-wide survey examining trends in paediatric rheumatology care…
- Jon Lampa on patient-reported outcomes from the NORD-STAR trial · 15 minAs part of The Lancet Rheumatology’s special issue on public and patient involvement in rheumatology, in this month’s episode, Aisling talks to Professor Jon Lampa about his…
- Coziana Ciurtin on long-term outcomes of childhood-onset Sjögren’s disease · 36 minIn this month’s episode we discuss childhood-onset Sjögren’s disease-a rare and under-researched rheumatic condition. Lack of robust clinical and immunological characterisation…
- Fiona Pearce and Rachel Tattersall on HLH mortality rates in Europe · 35 minThis months episode covers Hemophagocytic lymphohistiocytosis, or HLH, a rare, life-threatening disorder characterised by dysregulated immune activity resulting in systemic…
- John Isaacs and Josh Bennett on sarcopenia in rheumatoid arthritis · 19 minDuring this episode, Dr John Isaacs and Dr Josh Bennett from Newcastle University and the NIHR Newcastle Biomedical Research Centre, discuss sarcopenia - an age-related loss of…
- Dr Samuel Bitoun on machine learning to classify the focus score and Sjögren’s disease · 11 minThis month's episode covers Sjögren’s disease—an autoimmune condition that primarily affects areas of the body that produce fluids, such as tears and saliva. The cause of the…
- Ryan Hum on synovial immunopathology in psoriatic arthritis · 27 minIn today's episode, Sophie discusses psoriatic arthritis with Dr Ryan Hum from The University of Manchester. Psoriatic arthritis affects between 0.1% and 1% of the general…
- Scott Uhlrich on personalised gait retraining for knee osteoarthritis · 16 minIn this episode, we’re tackling a condition that affects over 374 million people worldwide—knee osteoarthritis (OA). As the most common site of OA, knee OA is a leading cause of…
- Mark Hancock on low back pain · 10 minIn this episode, we'll be discussing an issue that affects millions of people globally - low back pain. We will find out why the burden of low back pain is so high, why current…
- Vibeke Strand on polymyalgia rheumatica · 12 minIn this episode Professor Vibeke Strand discusses polymyalgia rheumatica (or PMR), a common inflammatory rheumatic disease that significantly impairs patients’ quality of life…
- Xue Li on access to biologics in the Asia-Pacific region · 20 minThis is a joint podcast between The Lancet Rheumatology and The Lancet Regional Health - Western Pacific with Prof Xue Li. Biologics have become a mainstay of treatment in…
- Sinisa Savic on treatment outcomes in VEXAS syndrome · 12 minIn this podcast, Professor Savic talks about his recent publication that looks at treatment outcomes in patients with VEXAS syndrome, as well as what clinicians should look out…
- Fabian Müller and Melanie Hagen on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy · 21 minThis is the third and final episode of our mini-series on cell-based therapies in rheumatology, with Professor Fabian Müller and Dr Melanie Hagen from the Erlangen University…
- Dominique Farge on allogeneic umbilical cord-derived mesenchymal stromal cells for systemic lupus erythematosus · 26 minThis is the second episode of a mini series on cell-based therapies in rheumatology, with Prof. Dominique Farge discussing the use of allogeneic umbilical cord-derived…
- Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease · 19 minThe first episode of a mini series on cell-based therapies in rheumatology, with Prof Rebecca Marsh and Grant Schulert discussing the use of allogeneic haematopoietic stem-cell…
- Bryant England on advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease · 9 minDr Bryant England discusses the use of TNF-inhibitor versus non-TNF inhibitor biological or targeted synthetic DMARDs for treatment of rheumatoid arthritis-associated ILD, and…
- Brooke Conley and Ivan Lin on the development of arthritis educational resources for Aboriginal and Torres Strait Islander peoples in Australia · 19 minDr Brooke Conley and Associate Professor Ivan Lin discuss their recent study on integrating evidence from lived experience of Aboriginal people and clinical practice guidelines…








